GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » Other Stockholders Equity

TVGN (Tevogen Bio Holdings) Other Stockholders Equity : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Other Stockholders Equity?

Tevogen Bio Holdings's Other Stockholders Equity for the quarter that ended in Dec. 2024 was $0.00 Mil.

Tevogen Bio Holdings's quarterly Other Stockholders Equity increased from Jun. 2024 ($-0.00 Mil) to Sep. 2024 ($0.00 Mil) but then declined from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Tevogen Bio Holdings's annual Other Stockholders Equity declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil) but then increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).


Tevogen Bio Holdings Other Stockholders Equity Historical Data

The historical data trend for Tevogen Bio Holdings's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Other Stockholders Equity Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
- - - -

Tevogen Bio Holdings Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tevogen Bio Holdings Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Tevogen Bio Holdings Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tevogen Bio Holdings Business Description

Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

From GuruFocus